PIK3CG and non-small cell lung carcinoma: In EGFR-mutant non-small cell lung cancer cell models, for instance, the sequential activation of PI3K/AKT and MAPK signalling co-operatively produced highly proliferative cells that survived exposure to EGFR inhibition24.